Integrated Diagnostics Holdings plc provided revenue guidance for the year 2021. In light of IDH's strong performance in the first quarter of the year and management's view of a sustained recovery going forward, it is upgrading guidance for full-year revenue growth of over 20% with a consolidated EBITDA margin in line with 2020 levels.